


DP Technology
Also known as DPTech
Builds AI-accelerated molecular simulation (DeePMD lineage), a research cloud, literature and lab tools, and science agents sold to universities, drug and materials companies.
Money and evidence
Latest round, Series C, 2025-12-24: the record then held no research entry for the company. The first research entry is dated 2026-03-01; the highest level so far is 4 (Tested in the physical world).
Rounds and research, on one timeline
- 2026-09-09Research
Level 4 · Tested in the physical world
Westlake University and DP Technology publish ProteinTalks in Nature, a virtual cell trained on drug-treated breast cancer proteomes whose drug picks were tested on three patients' organoids
A virtual cell is only useful if its picks hold up in experiments nobody had run, and this one sent its picks to patient organoids, a step the Xaira, Arc and UC San Diego virtual cells on the record did not take. It is three patients, one cancer type and the authors' own labs, and the 501-patient survival split is retrospective. It is the first DP Technology research on the record.
- 2026-03-01Research
Level 3 · Checked against existing evidence
RealPXRD-Solver, led by DP Technology, reads crystal structures off measured powder diffraction patterns, and solves 39 database entries whose structures had never been reported
Powder diffraction is what a chemist gets when a new material will not grow a single crystal, and earlier AI solvers worked on simulated patterns and fell over on measured ones, where peaks overlap, crystals line up one way and impurity phases show up. Coupled to an automated refinement pipeline, the model determined the structures of 39 materials in the Powder Diffraction File that had carried a unit cell but no atomic positions since they were first reported, work that normally takes an expert weeks an entry.
- 2025-12-24Series CRound
over 800M yuanCNY 6B post (≈ $855M) · stated by Bianews via Sina Finance
For: hiring and its science-discovery engine, with market expansion in research, life and materials science
HiringModels and platformCommercial roll-out
No lead named; PEdaily says total raised is now 'several billion yuan'. The valuation figure appears only in the Sina-carried piece.
Fortune Venture CapitalJingguorui FundBeijing AI Industry Investment FundBeijing Pharmaceutical and Health Industry Investment FundLenovo Capital ✓Yuanhe Puhua
- 2024-10-14Round (unnamed)Round
several hundred million yuan
For: hiring, full-stack software and roll-out in pharma, energy, chemicals and chips
HiringModels and platformCommercial roll-out
Cailian Press counted this as the seventh round, with total raised then over a billion yuan.
Beijing AI Industry Investment FundZhongguancun Science City Co.
- 2023-08-18Round (unnamed)Round
over 700M yuan
Not stated
The report names several industrial investors besides these four, without naming them or a lead.
Zhongyuan CapitalMSA CapitalLoyal Valley CapitalEvergreen Scitech Delta
- 2022-01-17Series BRound
tens of millions of US dollars
For: hiring and its micro-scale industrial design platform for drugs and materials
HiringModels and platform
Fourth round in 18 months; Qiji Capital was sole financial adviser.
Co-lead · Source Code Capital ✓Co-lead · Qiming Venture Partners ✓GL VenturesMPCi
- 2021-08-05Series ARound
tens of millions of US dollars
Not stated
36Kr and PEdaily say GL Ventures led, with Matrix Partners China and BioMap following; the recorded source (The Paper via Sina) says only that Hillhouse and Matrix invested, and adds Yuanjing as an existing investor following on. Full investor list from 36Kr (https://www.36kr.com/p/1331442281633793). Shengjing Jiacheng is added from its own WeChat account, which says it invested in three consecutive rounds (angel, Pre-A, A).
Lead · Hillhouse / GL VenturesMatrix Partners ChinaBioMapShengjing JiachengExisting investor · Yuanjing Capital ✓
- 2021-03Pre-ARound
undisclosed
Not stated
Shengjing Jiacheng is added from its own WeChat account, which says it invested in three consecutive rounds (angel, Pre-A, A).
- 2020-07AngelRound
undisclosed
Not stated
Recorded only in retrospect, in the August 2021 Series A report.
Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.
On the investors' own sites
Investors that name this company on their own site, in a portfolio or their own announcement. A ✓ in a round marks the same investor.
- Baidu Venturesbaidu-ventures.com ↗
- Qiming Venture Partnersqimingvc.com ↗
- Source Code Capitalsourcecodecap.com ↗
- Yuanjing Capitalvisionpluscapital.com ↗
- Crystal Streamcrystalstreamcap.cn ↗
- Lenovo Capitalcapital.lenovo.com ↗
Its investors also backed
Other companies on this page whose rounds name the same investor.
- GL VenturesHelixon (Earendil Labs), StoneWise, Zelixir, Deep Principle
- Qiming Venture PartnersBIOTREE, Insilico Medicine, Aureka Biotechnologies
- Baidu VenturesMoleculeMind, Insilico Medicine, Deep Principle
- Source Code CapitalMETiS TechBio, Deep Material
- Lenovo CapitalMoleculeMind, Deep Principle
- Fortune Venture CapitalBioGeometry
- Matrix Partners ChinaAureka Biotechnologies
- Shengjing JiachengBioGeometry